Answers are grounded in this paper and cite their sources.
We explored the ability of the low molecular weight, polyphenol-rich fractions obtained from chestnut shells to inhibit ferroptosis in Friedreich Ataxia (FRDA), an inherited neuro- and cardio-degenerative disease. We prepared an aqueous extract by an eco-sustainable method and obtained a polyphenol-rich fraction (fraction D) of molecular weight less than 1.0 kDa after molecular size fractionation. The total phenols were 173.28 ± 4.97 μg gallic acid equivalents/mg fraction, and analysis by UHPLC-ITMSn and RP-HPLC-UV revealed thirteen phenolic compounds with gallic acid and protocatechuic acid (PCA) as the most abundant (26.29 ± 2.19 and 4.93 ± 0.19 μg/mg fraction, respectively). Using a cellular assay based on patient-derived FRDA fibroblasts, we observed that chestnut shell dry extract at 20 µg/mL increased the survival of cells stressed with the ferroptosis inducer erastin from 8% to 45% and that this activity was dose-dependent. Fraction D at 20 µg/mL showed similar strong activity, increasing cell survival from 0.5% to 14% and decreasing lipid peroxidation by 42%. PCA, the most efficacious compound, doubled cell survival and decreased lipid peroxidation by 20%. Moreover, PCA increased the survival of cells in which frataxin was knocked down 1.5-fold and decreased ALOX12 expression. Our data suggest that PCA could be a promising molecule to explore FRDA pathophysiology.
No takes yet. Share an insight, caveat, or question.
Squillaci et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: